Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bank of America Corp (BAC)’s Tough Ending to the Week

Things were going so well. Bank of America Corp (NYSE:BAC) was inching its way back to its 52-week high of $12.42, but it topped out at $12.31 on Wednesday before falling, and falling some more. Though the stock is hovering around even now (1:10 p.m. EST), it’s been a tough couple of days for the bank’s stock. And though disappointing economic news may have started B of A’s descent, the ever-controversial topic of its CEO pay may keep it going.

Bank of America Corp (NYSE:BAC)

How it all began
Wednesday saw the release of January’s housing starts, and Americans were none too pleased with what they got. Housing starts were down 8.5% compared to December, showing a slowdown in the housing market’s recovery that was not expected. Also reported was news that permits are at a high not seen since 2008, and single-family home construction actually rose in January, but this good news wasn’t enough to support failing investor confidence.

On top of the disappointing January numbers, Wednesday’s release of the Fed’s minutes from its most recent FOMC meeting brought on another wave of investor concern for banks. The minutes revealed that many of the committee members were concerned with the rising cost of the Fed’s quantitative easing and would consider cutting the program early. Since part of the point of QE was to help raise housing prices and keep interest rates low, banks get some of the biggest benefits from the program.

The combination of the housing data and FOMC minutes took a big swing at stocks that are reliant upon the housing market’s recovery:

Company Price Change Since Monday Open
Bank of America (NYSE:BAC) -6.57%
Citigroup (NYSE:C) -3.90%
JPMorgan (NYSE:JPM) -1.46%
Wells Fargo (NYSE:WFC) 0.20%
Home Depot (NYSE:HD) -2.94%
Lowe’s (NYSE:LOW) -1.27%

Source: Yahoo! Finance.

So far today, the home improvement stocks and banks have all begun to rise, with the exception of B of A.

What may keep it going
So, if the other banks are beginning to recover from the shock of Wednesday’s news, why not Bank of America? Two words: executive pay. Now, the news that CEO Brian Moynihan’s compensation for 2012 topped $12 million between his salary and allotted shares was released on Tuesday before the housing debacle. But the debate over his 73% increase in pay may have been overshadowed by the news on the following day. Since there has been a slight recovery from the housing news, it makes sense that the attention would fall back onto Moynihan’s generous income.

There are (of course) arguments for both sides of the debate, but the debate itself is what may cause B of A to stay low. Since the bank’s stock is so highly traded, and therefore extremely volatile, investor sentiment is often a big determinant of which way the stock moves. A recent trend of reduced executive pay at other financial firms may put Moynihan and Bank of America in a negative light since the bank bucked that trend.

The article Bank of America’s Tough Ending to the Week originally appeared on and is written by Jessica Alling.

Fool contributor Jessica Alling has no position in any stocks mentioned, but you can contact her here. The Motley Fool recommends Home Depot, Loews, and Wells Fargo. The Motley Fool owns shares of Bank of America, Citigroup, JPMorgan Chase, Loews, and Wells Fargo.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!